S. Little

发表

Amplification and Overexpression of CACNA1E Correlates with Relapse in Favorable Histology Wilms' Tumors

Kathy Pritchard-Jones, Chris Jones, Boo Messahel, 2006, Clinical Cancer Research.

Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA.

A. Ashworth, J. Reis-Filho, Chris Jones, 2006, Genomics.

Cancer esearch apeutics , Targets , and Chemical Biology MT-Independent Temozolomide Resistance in Pediatric blastoma Cells Associated with a PI 3-Kinase – Mediated R / Stem Cell Gene Signature

D. Bax, G. Vassal, Chris Jones, 2010 .

/ Stem Cell Gene Signature HOX Mediated − Glioblastoma Cells Associated with a PI 3-Kinase MGMT-Independent Temozolomide Resistance in Pediatric

D. Bax, G. Vassal, Chris Jones, 2010 .

Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.

N. Rahman, S. Hanks, Chris Jones, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

A. Ashworth, J. Reis-Filho, R. Natrajan, 2007, The Journal of pathology.

Distinct Phenotypic Differences Associated with Differential Amplification of Receptor Tyrosine Kinase Genes at 4q12 in Glioblastoma

S. Al-Sarraj, Chris Jones, S. Little, 2013, PloS one.

Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.

S. Al-Sarraj, D. Bax, Chris Jones, 2012, Cancer research.

A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

A. Ashworth, S. Al-Sarraj, A. Grigoriadis, 2010, Clinical Cancer Research.

Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development

Paul Workman, Darren Hargrave, Chris Jones, 2009, PloS one.

Multifaceted Dysregulation of the Epidermal Growth Factor Receptor Pathway in Clear Cell Sarcoma of the Kidney

J. Reis-Filho, D. Bax, Chris Jones, 2007, Clinical Cancer Research.

Molecular profiling reveals frequent gain of MYCN and anaplasia‐specific loss of 4q and 14q in wilms tumor

A. Ashworth, James R. Anderson, T. Chagtai, 2011, Genes, chromosomes & cancer.

MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.

R. Reis, D. Bax, G. Vassal, 2010, Cancer research.

EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines

Paul Workman, Jorge S. Reis-Filho, Darren Hargrave, 2009, Clinical Cancer Research.

Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

J. Reis-Filho, Chris Jones, R. Natrajan, 2006, Cancer research.

Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines

J. Reis-Filho, S. Al-Sarraj, R. Reis, 2009 .

Wt1 is not essential for hematopoiesis in the mouse.

T. Enver, A. Schedl, K. Pritchard-Jones, 2005, Leukemia research.

Serum High Sensitivity C-Reactive Protein Poorly Predicts Bone Mineral Density: A NHANES 2017-2020 Analysis

S. Little, 2023, medRxiv.

A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome

N. Rahman, S. Hanks, K. Pritchard-Jones, 2004, Pediatric Nephrology.